CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.73B, above the global median of $1.15B
- FinancialsAltman Z-Score 6.42: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
1.73BUSDvs all stocks (USD)
Revenue (TTM)
102.92MUSDvs all stocks (USD)
Profit Margin
-73.63%vs Medical Devices peers
Beta
2.05xvs all stocks
52-Week Change
252.13%vs all stocks
Market Capitalization
1.73BUSDvs all stocks (USD)
Enterprise Value
1.71BUSDvs all stocks (USD)
Forward P/E
-75.78xvs Medical Devices peers
Price to Sales (TTM)
17.82xvs Medical Devices peers
Price to Book (MRQ)
9.58xvs Medical Devices peers
Enterprise to Revenue
16.65xvs Medical Devices peers
Enterprise to EBITDA
-33.97xvs Medical Devices peers
Gross Margin
68.92%vs Medical Devices peers
Profit Margin
-73.63%vs Medical Devices peers
Operating Margin
-50.84%vs Medical Devices peers
Return on Assets (TTM)
-11.16%vs Medical Devices peers
Return on Equity (TTM)
-35.17%vs Medical Devices peers
Revenue (TTM)
102.92MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4080USDUpdated Jul 18, 2026Quarterly Revenue Growth
25.00%vs Medical Devices peers
Gross Profit (TTM)
68.04MUSDvs all stocks (USD)
EBITDA (TTM)
-50.43MUSDvs all stocks (USD)
Net Income (TTM)
-75.77MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
24.99%vs Medical Devices peers
Operating Cash Flow (TTM)
-14.92MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
8.86MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
97.61MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
51.88MUSDFY2025 · Dec 31, 2025Gross Profit
45.73MUSDFY2025 · Dec 31, 2025Operating Income
-86.42MUSDvs all stocks (USD)
Pre-tax Income
-76.95MUSDFY2025 · Dec 31, 2025Income Tax Expense
110.00KUSDFY2025 · Dec 31, 2025Net Income
-77.06MUSDFY2025 · Dec 31, 2025EBIT
-75.46MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-69.66MUSDFY2025 · Dec 31, 2025Research & Development
36.26MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
95.89MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
5.91MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.49MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.3100USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.3100USDFY2025 · Dec 31, 2025Basic Shares Outstanding
247.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
247.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-77.06MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-35.40MUSDFY2025 · Dec 31, 2025Free Cash Flow
-38.75MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
154.50MUSDFY2025 · Dec 31, 2025Interest Paid
810.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-77.06MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
8.08MUSDFY2025 · Dec 31, 2025Stock-based Compensation
23.43MUSDFY2025 · Dec 31, 2025Other Non-cash Items
2.29MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.42MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.35MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.35MUSDFY2025 · Dec 31, 2025Other Financing Charges
-5.47MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
75.53MUSDFY2025 · Dec 31, 2025Shares Outstanding
261.20MSharesUpdated Jul 18, 2026Float Shares
190.78MSharesUpdated Jul 18, 2026Shares Short
28.74MSharesUpdated Jul 18, 2026Short Ratio
2.61daysvs all stocks
Short % of Shares Outstanding
14.07%vs all stocks
% Held by Insiders
12.10%vs all stocks
% Held by Institutions
55.38%vs all stocks
Total Cash (MRQ)
137.95MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.5280USDUpdated Jul 18, 2026Total Debt (MRQ)
19.76MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1033xvs Medical Devices peers
Current Ratio (MRQ)
4.03xvs Medical Devices peers
Book Value per Share (MRQ)
0.7320USDUpdated Jul 18, 2026Total Assets
296.53MUSDvs all stocks (USD)
Total Current Assets
249.10MUSDFY2025 · Dec 31, 2025Total Liabilities
100.55MUSDFY2025 · Dec 31, 2025Total Non-current Assets
47.43MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
35.44MUSDFY2025 · Dec 31, 2025Total Current Liabilities
65.12MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
150.49MUSDFY2025 · Dec 31, 2025Accounts Receivable
26.74MUSDFY2025 · Dec 31, 2025Inventory
61.39MUSDFY2025 · Dec 31, 2025Accounts Payable
5.44MUSDFY2025 · Dec 31, 2025Short-term Debt
2.68MUSDFY2025 · Dec 31, 2025Deferred Revenue
26.91MUSDFY2025 · Dec 31, 2025Other Current Liabilities
9.71MUSDFY2025 · Dec 31, 2025Long-term Debt
17.72MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
8.32MUSDFY2025 · Dec 31, 2025Common Stock (Book)
26.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-879.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
195.98MUSDvs all stocks (USD)
52-Week Low
1.32USDUpdated Jul 18, 202652-Week High
9.69USDUpdated Jul 18, 202652-Week Change
252.13%vs all stocks
Beta
2.05xvs all stocks
50-Day MA
5.90USDUpdated Jul 18, 2026200-Day MA
4.10USDUpdated Jul 18, 2026Avg 10-Day Volume
8.82MSharesUpdated Jul 18, 2026Avg 30-Day Volume
10.72MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.3000USDUpdated Jul 18, 2026Other Income / Expense
5.04MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.25Receivables vs revenue divergence: 2.54
High gross margins eroded by operating costsNotable
Gross Margin: 0.69Profit Margin: -0.74
Financial Health
Altman Z-Score 6.42: safe zoneNotable
Altman Z-Score: 6.42
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.73B, above the global median of $1.15BNotable
Market cap (USD): 1,732,062,797Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Nolato AB
Tier 1ProductionApproval-Gated PipelineRule
Tibet Cheezheng Tibetan Medicine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Harrow Inc.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Pharmablock Sciences Nanjing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Taysha Gene Therapies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow